论文信息 - S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) in Zusammenarbeit mit der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e. V.

S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) in Zusammenarbeit mit der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e. V.

Studienergebnisse Abstract ! This guideline updates a prior concensus re-commendation of the German Society for Diges-tive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary coop-eration with representatives of the German Society for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the

[1] G. Leontiadis,et al. Helicobacter pylori infection. , 2009, BMJ clinical evidence.

[2] K. Chayama,et al. Evaluation of Gastric Cancer Risk Using Topography of Histological Gastritis: A Large-scaled Cross-sectional Study , 2008, Digestive Diseases and Sciences.

[3] M. Stolte,et al. One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin , 2008, Helicobacter.

[4] M. Luppi,et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. , 2007, Blood.

[5] He-sheng Luo,et al. Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. , 2007, World journal of gastroenterology.

[6] F. Bazzoli,et al. Meta-analysis: Duration of First-Line Proton-Pump InhibitorBased Triple Therapy for Helicobacter pylori Eradication , 2007, Annals of Internal Medicine.

[7] B. Hunt,et al. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8] M. A. Tkachenko,et al. Dramatic Changes in the Prevalence of Helicobacter pylori Infection During Childhood: A 10-year Follow-up Study in Russia , 2007, Journal of pediatric gastroenterology and nutrition.

[9] M. Plummer,et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.

[10] F. Mégraud,et al. Eradication therapy for Helicobacter pylori. , 2007, Gastroenterology.

[11] L. Fischbach,et al. Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori , 2007, Alimentary pharmacology & therapeutics.

[12] D. Graham,et al. A Report Card to Grade Helicobacter pylori Therapy , 2007, Helicobacter.

[13] G. Pizzolo,et al. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[14] W. Fischbach,et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series , 2007, Gut.

[15] J. Crabtree,et al. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. , 2007, Gastroenterology.

[16] P. Tugwell,et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17] M. Kist. Helicobacter pylori: primary antimicrobial resistance and first-line treatment strategies. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18] A. Ferreri,et al. Primary diffuse large B-cell lymphoma of the stomach. , 2007, Critical reviews in oncology/hematology.

[19] A. Svennerholm,et al. Progress in vaccine development against Helicobacter pylori. , 2007, FEMS immunology and medical microbiology.

[20] C. Hawkey,et al. Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study. , 2007, Gastroenterology.

[21] C. Hassan,et al. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis , 2007, Gut.

[22] S. Koletzko,et al. Evaluation of a novel rapid one-step monoclonal chromatographic immunoassay for detection of Helicobacter pylori in stool from children , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[23] M. Raderer,et al. Therapy of gastric mucosa-associated lymphoid tissue lymphoma , 2007, Expert opinion on pharmacotherapy.

[24] V. Wong,et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial , 2007, The Lancet.

[25] A. Barkun,et al. Antimicrobial Drugs and Community–acquired Clostridium difficile–associated Disease, UK , 2007, Emerging infectious diseases.

[26] F. Mégraud,et al. Helicobacter pylori Detection and Antimicrobial Susceptibility Testing , 2007, Clinical Microbiology Reviews.

[27] F. Gottrand,et al. Results from the Pediatric European Register for Treatment of Helicobacter pylori (PERTH) , 2007, Helicobacter.

[28] S. Koletzko,et al. Evaluation of the Novel Helicobacter pylori ClariRes Real-Time PCR Assay for Detection and Clarithromycin Susceptibility Testing of H. pylori in Stool Specimens from Symptomatic Children , 2007, Journal of Clinical Microbiology.

[29] S. Stewart,et al. Stress-ulcer prophylaxis for general medical patients: a review of the evidence. , 2007, Journal of hospital medicine.

[30] P. Sherman,et al. Meta‐analysis: Helicobacter pylori eradication treatment efficacy in children , 2007, Alimentary pharmacology & therapeutics.

[31] M. Bellini,et al. Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and Probiotics , 2007, The American Journal of Gastroenterology.

[32] P. Malfertheiner,et al. Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic , 2007, Expert opinion on pharmacotherapy.

[33] M. Kusano,et al. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach , 2007, British Journal of Cancer.

[34] B. Tepes. Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy , 2007, Scandinavian journal of gastroenterology.

[35] T Rokkas,et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.

[36] G. Capurso,et al. Corpus‐predominant gastritis as a risk factor for false‐negative 13C‐urea breath test results , 2006, Alimentary pharmacology & therapeutics.

[37] M. Granström,et al. Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populations. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38] E. Ierardi,et al. Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial , 2006, Alimentary pharmacology & therapeutics.

[39] J. Tong,et al. Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy , 2006, Alimentary pharmacology & therapeutics.

[40] J. Hallas,et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study , 2006, BMJ : British Medical Journal.

[41] D. Drossman,et al. Rome III: New standard for functional gastrointestinal disorders. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[42] S. Miehlke,et al. Effective regimens for the treatment of Helicobacter pylori infection , 2006, Expert opinion on investigational drugs.

[43] C. Lamers,et al. The 13carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting , 2006, Alimentary pharmacology & therapeutics.

[44] L. Marzio,et al. Role of the Preliminary Susceptibility Testing for Initial and After Failed Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and Esomeprazole , 2006, Helicobacter.

[45] G. Brandi,et al. Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa , 2006, The American Journal of Gastroenterology.

[46] S. Koletzko,et al. Esomeprazole-Based 1-Week Triple Therapy Directed by Susceptibility Testing for Eradication of Helicobacter pylori Infection in Children , 2006, Journal of pediatric gastroenterology and nutrition.

[47] M. Stolte,et al. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro‐oesophageal reflux disease in Western patients with non‐ulcer dyspepsia , 2006, Alimentary pharmacology & therapeutics.

[48] K. Chu,et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[49] R. Hunt,et al. The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis , 2006, The American Journal of Gastroenterology.

[50] M. Stolte,et al. Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin , 2006, Alimentary pharmacology & therapeutics.

[51] K. Turetschek,et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52] H. Brenner,et al. Clustering of Helicobacter pylori infection in couples: differences between high- and low-prevalence population groups. , 2006, Annals of epidemiology.

[53] J. Gisbert,et al. Accuracy of Monoclonal Stool Antigen Test for the Diagnosis of H. pylori Infection: A Systematic Review and Meta-Analysis , 2006, The American Journal of Gastroenterology.

[54] C. O'Morain,et al. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. , 2006, Pathology, research and practice.

[55] J. Emberson,et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.

[56] F. Mégraud,et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe , 2006, Gut.

[57] M. Gotteland,et al. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? , 2006, Alimentary pharmacology & therapeutics.

[58] S. Lightfoot,et al. Successful Treatment of Helicobacter Pylori-Negative Gastric MALT Lymphoma With Rituximab , 2006, Digestive Diseases and Sciences.

[59] Yoshinori Kikuchi,et al. Influence of urease activity in the intestinal tract on the results of 13C‐urea breath test , 2006, Journal of gastroenterology and hepatology.

[60] C. Di Lorenzo,et al. Childhood functional gastrointestinal disorders: child/adolescent. , 2006, Gastroenterology.

[61] Víctor Abraira,et al. Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis , 2006, The American Journal of Gastroenterology.

[62] R. Hunt,et al. Levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence? , 2006, Alimentary pharmacology & therapeutics.

[63] F. Chan,et al. Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors , 2006, The American Journal of Gastroenterology.

[64] Mario Plebani,et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[65] E. Waclawski,et al. Are endoscopy nurses at risk of infection with Helicobacter pylori from their work? , 2006, Occupational medicine.

[66] Ziding Feng,et al. A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska. , 2006, The Journal of infectious diseases.

[67] M. Stolte,et al. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double‐blind, placebo‐controlled multicentre trial , 2006, Alimentary pharmacology & therapeutics.

[68] R. Mahfouz,et al. Does Helicobacter pylori colonize the nasopharynx of children and contribute to their middle ear disease? , 2006, Acta oto-laryngologica.

[69] M. Stolte,et al. Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series , 2006, Leukemia & lymphoma.

[70] J. Gisbert,et al. Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure , 2006, Alimentary pharmacology & therapeutics.

[71] M. Kivi,et al. Helicobacter pylori occurrence and transmission: A family affair? , 2006, Scandinavian journal of infectious diseases.

[72] A. Barkun,et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[73] Ken Dewar,et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[74] A. May,et al. Capsule endoscopy in gastrointestinal lymphomas. , 2005, Endoscopy.

[75] L. Laine,et al. The effect of GI bleeding on Helicobacter pylori diagnostic testing: a prospective study at the time of bleeding and 1 month later. , 2005, Gastrointestinal endoscopy.

[76] U. Jaeger,et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77] A. Chott,et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas , 2005, Gut.

[78] M. Asaka,et al. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura , 2005, Annals of Hematology.

[79] A. Francavilla,et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. , 2005, Gastroenterology.

[80] M. Stolte,et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81] N. Talley. American Gastroenterological Association medical position statement: evaluation of dyspepsia. , 2005, Gastroenterology.

[82] C. Hawkey,et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin , 2005, Alimentary pharmacology & therapeutics.

[83] A. Salar,et al. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84] J. Gisbert,et al. Helicobacter pylori“Rescue” Therapy After Failure of Two Eradication Treatments , 2005, Helicobacter.

[85] N. Willich,et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86] J. J. Tai,et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. , 2005, Journal of the National Cancer Institute.

[87] T. Falsafi,et al. Application of a Stool Antigen Test To Evaluate the Incidence of Helicobacter pylori Infection in Children and Adolescents from Tehran, Iran , 2005, Clinical Diagnostic Laboratory Immunology.

[88] C. Copie-Bergman,et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89] T. Morizane,et al. Helicobacter pylori Infection in Dental Professionals: A 6‐year Prospective Study , 2005, Helicobacter.

[90] H. Matsumoto,et al. Long‐term clinical outcome of Helicobacter pylori eradication for gastric mucosa‐associated lymphoid tissue lymphoma with a reference to second‐line treatment , 2005, Cancer.

[91] N. Talley,et al. The Epidemiology of Childhood Recurrent Abdominal Pain in Western Countries: A Systematic Review , 2005, The American Journal of Gastroenterology.

[92] M. Struelens,et al. Prevalence and risk-factors for Helicobacter pylori infection in urban and rural Beninese populations. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[93] A. Ozdarendeli,et al. Detection of Helicobacter pylori in Children with Otitis Media with Effusion: A Preliminary Report , 2005, The Laryngoscope.

[94] S. Koletzko. Noninvasive diagnostic tests for Helicobacter pylori infection in children. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[95] O. Nyrén,et al. Helicobacter pylori Infection and Abdominal Symptoms Among Swedish School Children , 2005, Journal of pediatric gastroenterology and nutrition.

[96] J. Gisbert,et al. Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users , 2005, Alimentary pharmacology & therapeutics.

[97] T. Mine,et al. Effect of Helicobacter pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura—A Randomized Controlled Trial , 2005, The American Journal of Gastroenterology.

[98] K. Wada,et al. Preventive therapy for non‐steroidal anti‐inflammatory drug‐induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled‐study of the preventive effects of lansoprazole or famotidine , 2005, Alimentary pharmacology & therapeutics.

[99] Z. Şenses,et al. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? , 2005, Journal of tropical pediatrics.

[100] N. Konstantopoulos,et al. Evaluation of a Novel Rapid One-Step Immunochromatographic Assay for Detection of Monoclonal Helicobacter pylori Antigen in Stool Samples from Children , 2005, Journal of Clinical Microbiology.

[101] R. Hunt,et al. Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. , 2005, World journal of gastroenterology.

[102] M. Cattaruzza,et al. Does hospital work constitute a risk factor for Helicobacter pylori infection? , 2005, Journal of Hospital Infection.

[103] R. Laheij,et al. The importance of corpus biopsies for the determination of Helicobacter pylori infection. , 2005, The Netherlands journal of medicine.

[104] M. Granström,et al. Long‐term follow‐up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome , 2005, Alimentary pharmacology & therapeutics.

[105] E. Pedrinis,et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106] M. Reilly,et al. Helicobacter pylori status in family members as risk factors for infection in children , 2005, Epidemiology and Infection.

[107] H. Rautelin,et al. Helicobacter pylori in children who are prone to upper respiratory tract infections. , 2005, Archives of otolaryngology--head & neck surgery.

[108] R. Tsang,et al. Radiation therapy for localized low‐grade non‐Hodgkin's lymphomas , 2005, Hematological oncology.

[109] F. Mégraud. Comparison of non-invasive tests to detect Helicobacter pylori infection in children and adolescents: results of a multicenter European study. , 2005, The Journal of pediatrics.

[110] M. Janssen,et al. Meta‐analysis: the influence of pre‐treatment with a proton pump inhibitor on Helicobacter pylori eradication , 2005, Alimentary pharmacology & therapeutics.

[111] V. Wong,et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. , 2005, The New England journal of medicine.

[112] Nayoung Kim,et al. Seroconversion of Helicobacter pylori in Korean male employees , 2005, Scandinavian journal of gastroenterology.

[113] H. Brenner,et al. Patterns of alcohol consumption and Helicobacter pylori infection: results of a population‐based study from Germany among 6545 adults , 2005, Alimentary pharmacology & therapeutics.

[114] F. Gottrand,et al. Helicobacter pylori Infection Is Not Associated With Specific Symptoms in Nonulcer-Dyspeptic Children , 2005, Pediatrics.

[115] L. Fischbach,et al. Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies , 2004, Alimentary pharmacology & therapeutics.

[116] J. Gisbert,et al. Review article: 13C‐urea breath test in the diagnosis of Helicobacter pylori infection – a critical review , 2004, Alimentary pharmacology & therapeutics.

[117] R. Eliakim,et al. Comparison of Invasive and Non-Invasive Tests Diagnosis and Monitoring of Helicobacter Pylori Infection in Children , 2004, Journal of pediatric gastroenterology and nutrition.

[118] J. Houghton,et al. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. , 2004, Gene.

[119] D. Symmons,et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review , 2004, BMJ : British Medical Journal.

[120] I. Kovalszky,et al. Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single‐center experience , 2004, Clinical transplantation.

[121] F. Perna,et al. Role of Noninvasive Tests (13C‐Urea Breath Test and Stool Antigen Test) as Additional Tools in Diagnosis of Helicobacter Pylori Infection in Patients with Atrophic Body Gastritis , 2004, Helicobacter.

[122] V. Wong,et al. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. , 2004, Gastroenterology.

[123] M. Achtman,et al. Helicobacter pylori: recombination, population structure and human migrations. , 2004, International journal of medical microbiology : IJMM.

[124] H. Rautelin,et al. Symptomatic Response to Helicobacter Pylori Eradication in Children With Recurrent Abdominal Pain:: Double Blind Randomized Placebo-controlled Trial , 2004, Journal of clinical gastroenterology.

[125] A. Chott,et al. Translocation t(11;18)(q21;q21) Is Not Predictive of Response to Chemotherapy with 2CdA in Patients with Gastric MALT Lymphoma , 2004, Oncology.

[126] D. Forman,et al. Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis , 2004, The American Journal of Gastroenterology.

[127] F. Mégraud. H pylori antibiotic resistance: prevalence, importance, and advances in testing , 2004, Gut.

[128] D. Graham,et al. Challenge model for Helicobacter pylori infection in human volunteers , 2004, Gut.

[129] F. Gottrand,et al. Acquisition of Helicobacter pylori infection after outbreaks of gastroenteritis: prospective cohort survey in institutionalised young people , 2004, BMJ : British Medical Journal.

[130] I. Alvarado,et al. The Role of Surgery in Primary Gastric Lymphoma: Results of a Controlled Clinical Trial , 2004, Annals of surgery.

[131] M. Boaz,et al. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole , 2004, Alimentary pharmacology & therapeutics.

[132] U. Klotz,et al. CYP2C19 polymorphism and proton pump inhibitors. , 2004, Basic & clinical pharmacology & toxicology.

[133] M. Rafeey,et al. Relationship between endoscopic nodular gastritis and Helicobacter pylori infection in children. , 2004, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[134] F. Mégraud,et al. Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type , 2004, Gut.

[135] T. Meyer,et al. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. , 2004, Vaccine.

[136] M. Vieth,et al. Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue , 2004, Modern Pathology.

[137] T. Azuma,et al. Meta-analysis of the relationship between CagA seropositivity and gastric cancer. , 2004, Gastroenterology.

[138] M. Janssen,et al. The influence of pretreatment on cure rates of Helicobacter pylori eradication. , 2004, The Netherlands journal of medicine.

[139] F. Perna,et al. Effect of Proton Pump Inhibitors and Antacid Therapy on 13C Urea Breath Tests and Stool Test for Helicobacter Pylori Infection , 2004, American Journal of Gastroenterology.

[140] N. Yamada,et al. Topography of chronic active gastritis in Helicobacter pylori-positive Asian populations: age-, gender-, and endoscopic diagnosis-matched study , 2004, Journal of Gastroenterology.

[141] N. Ukarapol,et al. Recurrent abdominal pain in children: the utility of upper endoscopy and histopathology. , 2004, Singapore medical journal.

[142] A. Straszak,et al. Efficacy and Tolerability of Pantoprazole Compared with Misoprostol for the Prevention of NSAID-Related Gastrointestinal Lesions and Symptoms in Rheumatic Patients , 2004, Digestion.

[143] A. Barkun,et al. Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia , 2004, Alimentary pharmacology & therapeutics.

[144] H. Brenner,et al. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[145] Rohit Kohli,et al. Differential diagnosis of recurrent abdominal pain: new considerations. , 2004, Pediatric annals.

[146] D. Graham,et al. False Negative Urea Breath Tests with H2‐Receptor Antagonists: Interactions Between Helicobacter pylori Density and pH , 2004, Helicobacter.

[147] P. Malfertheiner,et al. Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding. , 2004, Zeitschrift fur Gastroenterologie.

[148] D. Forman,et al. Impact of Helicobacter pylori on society—role for a strategy of ‘search and eradicate’ , 2004, Alimentary pharmacology & therapeutics.

[149] Justin C.Y. Wu,et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial , 2004, Gut.

[150] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[151] M. Stolte,et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series , 2003, Gut.

[152] L. Engstrand,et al. Concordance of Helicobacter pylori Strains within Families , 2003, Journal of Clinical Microbiology.

[153] A. Chott,et al. Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma , 2003, Oncology.

[154] P. Unge. Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[155] R. Tsang,et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[156] P. Malfertheiner,et al. European multicentre validation trial of two new non‐invasive tests for the detection of Helicobacter pylori antibodies: urine‐based ELISA and rapid urine test , 2003, Alimentary pharmacology & therapeutics.

[157] R. Corrêa-Oliveira,et al. Transmission of Helicobacter pylori infection in families of preschool‐aged children from Minas Gerais, Brazil , 2003, Tropical medicine & international health : TM & IH.

[158] F. Cavalli,et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. , 2003, Blood.

[159] J. Gisbert,et al. Meta‐analysis: proton pump inhibitors vs. H2‐receptor antagonists — their efficacy with antibiotics in Helicobacter pylori eradication , 2003, Alimentary pharmacology & therapeutics.

[160] R. Hunt,et al. Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods , 2003, Antimicrobial Agents and Chemotherapy.

[161] K. Chu,et al. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial , 2003, Alimentary pharmacology & therapeutics.

[162] O. Hosokawa,et al. Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Ménètrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. , 2003, Internal medicine.

[163] F. Perna,et al. Susceptibility of Helicobacter pylori to metronidazole , 2003, American Journal of Gastroenterology.

[164] Chia‐Long Lee,et al. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. , 2003, Archives of internal medicine.

[165] L. Cohen,et al. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia , 2003, American Journal of Gastroenterology.

[166] P. Malfertheiner,et al. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia , 2003, Alimentary pharmacology & therapeutics.

[167] M. Vieth,et al. A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and Clarithromycin , 2003, Helicobacter.

[168] O. P. Mishra,et al. Helicobacter pylori infection and recurrent abdominal pain in children. , 2003, Journal of tropical pediatrics.

[169] K. Haruma,et al. The long‐term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis , 2003, Alimentary pharmacology & therapeutics.

[170] R. Marmo,et al. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[171] P. Malfertheiner,et al. What constitutes failure for Helicobacter pylori eradication therapy? , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[172] N. Konstantopoulos,et al. Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children , 2003, Gut.

[173] J. Gisbert,et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis , 2003, Alimentary pharmacology & therapeutics.

[174] D. Graham,et al. Meta‐analysis: proton pump inhibitor or H2‐receptor antagonist for Helicobacter pylori eradication , 2003, Alimentary pharmacology & therapeutics.

[175] D. Graham,et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors , 2003, American Journal of Gastroenterology.

[176] H. Brenner,et al. Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. , 2003, Journal of psychosomatic research.

[177] D. Schilling,et al. A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[178] G. Amann,et al. Helicobacter pylori in Children and Adolescents: Increase of Primary Clarithromycin Resistance, 1997–2000 , 2003, Journal of pediatric gastroenterology and nutrition.

[179] W. Hui,et al. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long‐term NSAIDs: a double‐blind, placebo‐controlled trial , 2003, Alimentary pharmacology & therapeutics.

[180] F. Mégraud,et al. Which Test to Use to Detect Helicobacter pylori Infection in Patients With Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma? , 2003, American Journal of Gastroenterology.

[181] T. D. da Silveira,et al. Endoscopic Nodular Gastritis: An Endoscopic Indicator of High-Grade Bacterial Colonization and Severe Gastritis in Children With Helicobacter pylori , 2003, Journal of pediatric gastroenterology and nutrition.

[182] D. Aust,et al. Detection of Helicobacter pylori in Paraffin-Embedded and in Shock-Frozen Gastric Biopsy Samples by Fluorescent In Situ Hybridization , 2003, Journal of Clinical Microbiology.

[183] G. Losonsky,et al. B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals. , 2003, Vaccine.

[184] G. Alfvén. One hundred cases of recurrent abdominal pain in children: diagnostic procedures and criteria for a psychosomatic diagnosis , 2003, Acta paediatrica.

[185] V. Wong,et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. , 2002, The New England journal of medicine.

[186] L. Laine,et al. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies , 2002, American Journal of Gastroenterology.

[187] S. Koletzko,et al. Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains in gastric biopsies from children , 2002, Alimentary pharmacology & therapeutics.

[188] T. Monath,et al. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers , 2002, Gut.

[189] L. Hutwagner,et al. Seroincidence of Helicobacter pylori infection in a cohort of rural Bolivian children: acquisition and analysis of possible risk factors. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[190] C. O'Morain,et al. Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5‐Year Follow‐Up Study , 2002, Helicobacter.

[191] N. Konstantopoulos,et al. Reinfection rate in children after successful Helicobacter pylori eradication , 2002, European journal of gastroenterology & hepatology.

[192] M. Stolte,et al. Features of gastritis predisposing to gastric adenoma and early gastric cancer , 2002, Journal of clinical pathology.

[193] R. Brezinschek,et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[194] A. Blum,et al. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial , 2002, Gut.

[195] H. Müller-Hermelink,et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori , 2002, The Lancet.

[196] M. Stolte,et al. Close correlation of intestinal metaplasia and corpus gastritis in patients infected with Helicobacter pylori. , 2002, Zeitschrift fur Gastroenterologie.

[197] P. Malfertheiner,et al. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. , 2002, Journal of medical microbiology.

[198] P. Malfertheiner,et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme , 2002, Alimentary pharmacology & therapeutics.

[199] Norikazu Yoshimura,et al. Diagnostic accuracy of the 13C-urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study , 2002, American Journal of Gastroenterology.

[200] E. Kuipers,et al. Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy , 2002, American Journal of Gastroenterology.

[201] H. Brenner,et al. Role of infected parents in transmission of Helicobacter pylori to their children , 2002, The Pediatric infectious disease journal.

[202] K. Chu,et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. , 2002, The New England journal of medicine.

[203] M. Becker,et al. 13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in children , 2002, BMC gastroenterology.

[204] M. Stolte,et al. Helicobacter and gastric MALT lymphoma , 2002, Gut.

[205] Á. Lanas,et al. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin , 2002, Alimentary pharmacology & therapeutics.

[206] J. Atherton,et al. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding , 2002, Alimentary pharmacology & therapeutics.

[207] K. Goodman,et al. Isolation and Genotyping of Helicobacter pylori from Untreated Municipal Wastewater , 2002, Applied and Environmental Microbiology.

[208] A. Soweid,et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. , 2002, Gastrointestinal endoscopy.

[209] P. Strisciuglio,et al. Antral Nodularity and Positive CagA Serology are Distinct and Relevant Markers of Severe Gastric Inflammation in Children with Helicobacter pylori Infection , 2002, Helicobacter.

[210] T. Celkan,et al. Radiological features in paediatric primary gastric MALT lymphoma and association with Helicobacter pylori , 2002, Pediatric Radiology.

[211] U. Klotz,et al. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). , 2002, Archives of internal medicine.

[212] D. Graham,et al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. , 2002, Archives of internal medicine.

[213] B. E. C. Oiffier,et al. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma , 2002 .

[214] Justin C.Y. Wu,et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial , 2002, The Lancet.

[215] P. Malfertheiner,et al. [Insufficient validity of a rapid blood test for diagnosis of Helicobacter pylori infection]. , 2001, Medizinische Klinik.

[216] D. Fan,et al. Association of H. pylori infection with gastric carcinoma: a Meta analysis. , 2001, World journal of gastroenterology.

[217] T. Meyer,et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. , 2001, Vaccine.

[218] Ross D. Shachter,et al. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. , 2001, Vaccine.

[219] A. Sahai,et al. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage , 2001, Alimentary pharmacology & therapeutics.

[220] P. Malfertheiner,et al. A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer , 2001, Alimentary pharmacology & therapeutics.

[221] T. Molina,et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. , 2001, Gastroenterology.

[222] A. Cheng,et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[223] B. Drumm,et al. Limitations to carbon 13-labeled urea breath testing for Helicobacter pylori in infants. , 2001, The Journal of pediatrics.

[224] A. Axon,et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. , 2001, Gastroenterology.

[225] M. Färkkilä,et al. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia , 2001, American Journal of Gastroenterology.

[226] O. Herbarth,et al. Five- to 7-Year-Old Children With Helicobacter pylori Infection Are Smaller Than Helicobacter-Negative Children: A Cross-Sectional Population-Based Study of 3,315 Children , 2001, Journal of pediatric gastroenterology and nutrition.

[227] L. Hansson,et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.

[228] N. Willich,et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[229] S. Koletzko,et al. Infants differ from teenagers: use of non-invasive tests for detection of Helicobacter pylori infection in children , 2001, European journal of gastroenterology & hepatology.

[230] A. Helicobacter,et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[231] A. Pærregaard,et al. Treatment of Helicobacter pylori in Children With Recurrent Abdominal Pain , 2001, Helicobacter.

[232] F. Granath,et al. Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. , 2001, Gastroenterology.

[233] B. Burnand,et al. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia , 2001, American Journal of Gastroenterology.

[234] C. Dupont,et al. Clarithromycin Resistance and Eradication ofHelicobacter pylori in Children , 2001, Antimicrobial Agents and Chemotherapy.

[235] G. Losonsky,et al. Safety and Immunogenicity of Oral Inactivated Whole-CellHelicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection , 2001, Infection and Immunity.

[236] M. Seto,et al. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. , 2001, Gastroenterology.

[237] D. Graham,et al. Isolation of helicobacter pylori from sheep—implications for transmission to humans , 2001, American Journal of Gastroenterology.

[238] H. Müller-Hermelink,et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[239] F. Chan,et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.

[240] N. Konstantopoulos,et al. Evaluation of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children , 2001, American Journal of Gastroenterology.

[241] T. Molina,et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pyloritreatment , 2001, Gut.

[242] M. Luppi,et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. , 2001, Blood.

[243] Ming-Qing Du,et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy , 2001, The Lancet.

[244] David B. Schauer,et al. Emergence of Diverse HelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases , 2001, Clinical Microbiology Reviews.

[245] C. Dupont,et al. High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children , 2001, Journal of Clinical Microbiology.

[246] A. Mäkipernaa,et al. Helicobacter pylori and Iron Deficiency Anaemia in Children , 2001, Scandinavian journal of gastroenterology.

[247] G. Manes,et al. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy , 2001, Alimentary pharmacology & therapeutics.

[248] A. Ferreri,et al. Prognostic Significance of the Histopathologic Recognition of Low-and High-Grade Components in Stage I-II B-Cell Gastric Lymphomas , 2001, The American journal of surgical pathology.

[249] M. Stolte,et al. Gastric polyps: an update of their pathology and biological significance , 2000, Virchows Archiv.

[250] Lise,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[251] J. Burnie,et al. An association between sudden infant death syndrome (SIDS) andHelicobacter pylori infection , 2000, Archives of disease in childhood.

[252] H. Müller-Hermelink,et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. , 2000, Gastroenterology.

[253] T. Stallmach,et al. Helicobacter pylori Infection in Recurrent Abdominal Pain , 2000, Journal of pediatric gastroenterology and nutrition.

[254] S. Bhakdi,et al. Helicobacter pylori: Clonal Population Structure and Restricted Transmission within Families Revealed by Molecular Typing , 2000, Journal of Clinical Microbiology.

[255] M. Dyer,et al. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. , 2000, The American journal of pathology.

[256] P. Apfalter,et al. Two Enzyme Immunoassays and PCR for Detection ofHelicobacter pylori in Stool Specimens from Pediatric Patients before and after Eradication Therapy , 2000, Journal of Clinical Microbiology.

[257] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[258] N. York,et al. Treating H. pylori shorter than one week - a real future perspective? , 2000, Zeitschrift fur Gastroenterologie.

[259] P. Malfertheiner,et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany , 2000, International journal of cancer.

[260] S. Hernández-Díaz,et al. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.

[261] L. Signorello,et al. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma – a population-based study in Sweden , 2000, British Journal of Cancer.

[262] A. Wolk,et al. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: A population‐based case‐control study in Sweden , 2000, International journal of cancer.

[263] J. Sung,et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. , 2000, Gastroenterology.

[264] A. Verbeek,et al. Diagnostic performance of biopsy-based methods for determination of Helicobacter pylori infection without a reference standard. , 2000, Journal of clinical epidemiology.

[265] P. Marynen,et al. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. , 2000, Blood.

[266] Y. Ni,et al. Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. , 2000, The Journal of pediatrics.

[267] Kamada,et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis , 2000, Alimentary pharmacology & therapeutics.

[268] Gené,et al. A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.

[269] J. Lindeman,et al. Effect of Helicobacter pylorieradication on chronic gastritis during omeprazole therapy , 2000, Gut.

[270] M. Stolte,et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. , 2000, Gastroenterology.

[271] G. Rocha,et al. Immunoblot Analysis of Humoral Immune Response to Helicobacter pylori in Children with and without Duodenal Ulcer , 2000, Journal of Clinical Microbiology.

[272] C. O'Morain,et al. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding , 2000, American Journal of Gastroenterology.

[273] E. Hohmann,et al. Pilot Study of phoP/phoQ-DeletedSalmonella enterica Serovar Typhimurium ExpressingHelicobacter pylori Urease in Adult Volunteers , 2000, Infection and Immunity.

[274] Á. Lanas,et al. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin , 2000 .

[275] P. Marynen,et al. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. , 2000, The American journal of pathology.

[276] J. Yahalom,et al. Low-grade MALT lymphoma of the stomach: a review of treatment options. , 2000, International journal of radiation oncology, biology, physics.

[277] M. Seto,et al. Helicobacter pylori and the t(11;18)(q21;q21) Translocation in Gastric Low‐grade B‐Cell Lymphoma of Mucosa‐associated Lymphoid Tissue Type , 2000, Japanese journal of cancer research : Gann.

[278] A. Andriulli,et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. , 2000, The New England journal of medicine.

[279] D. Graham,et al. Therapy of Helicobacter pylori: current status and issues. , 2000, Gastroenterology.

[280] J. Lee,et al. Effect of Helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection , 2000, Acta paediatrica.

[281] S. Koletzko,et al. helicobacter pylori Infection in Children: A Consensus Statement , 2000 .

[282] C. Dupont,et al. Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children , 2000, The Pediatric infectious disease journal.

[283] P. Correa,et al. Transmission of Helicobacter pylori among siblings , 2000, The Lancet.

[284] M. Rawlins,et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs , 2000, Gut.

[285] Vakil,et al. Recurrent symptoms and gastro‐oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.

[286] M. Färkkilä,et al. Diagnosis of Helicobacter pylori Infection in Patients with Atrophic Gastritis: Comparison of Histology, 13C-Urea Breath Test, and Serology , 2000, Scandinavian journal of gastroenterology.

[287] T. Haggerty,et al. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. , 1999, JAMA.

[288] L. Hansson,et al. Occupational exposures and risk of gastric cancer in a population-based case-control study. , 1999, Cancer research.

[289] Ross D. Shachter,et al. Helicobacter pylori Vaccine Development and Use: A Cost‐Effectiveness Analysis Using the Institute of Medicine Methodology , 1999, Helicobacter.

[290] S. Bhakdi,et al. One-step polymerase chain reaction-based typing of Helicobacter pylori vacA gene: association with gastric histopathology , 1999, Medical Microbiology and Immunology.

[291] R. Spiller,et al. Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study , 1999, Antimicrobial Agents and Chemotherapy.

[292] K. Killeen,et al. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. , 1999, Vaccine.

[293] J. Sung,et al. Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission , 1999, American Journal of Gastroenterology.

[294] C. Macarthur,et al. Helicobacter pylori and childhood recurrent abdominal pain: community based case-control study , 1999, BMJ.

[295] J. Byles,et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis , 1999, American Journal of Gastroenterology.

[296] D. Graham,et al. Normalizing results of 13C-urea breath testing for CO2 production rates in children. , 1999, Journal of pediatric gastroenterology and nutrition.

[297] F. Gottrand,et al. Natural Outcome of Helicobacter pylori Infection in Asymptomatic Children: A Two-year Follow-up Study , 1999, Pediatrics.

[298] P. Malfertheiner,et al. Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting , 1999, American Journal of Gastroenterology.

[299] L. Daly,et al. Low rates of Helicobacter pylori reinfection in children. , 1999, Gastroenterology.

[300] Jeffrey E. Lee,et al. Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial , 1999, Annals of Internal Medicine.

[301] D. Graham,et al. Helicobacter pylori in sheep milk , 1999, The Lancet.

[302] M. Stolte,et al. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. , 1999, European journal of gastroenterology & hepatology.

[303] Danesh. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies , 1999, Alimentary pharmacology & therapeutics.

[304] F. Roudot-thoraval,et al. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa. , 1999, European journal of gastroenterology & hepatology.

[305] H. Straatman,et al. Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis , 1999, Alimentary pharmacology & therapeutics.

[306] S. Kim,et al. Randomized Placebo‐Controlled Trial of Helicobacter pylori Eradication for Iron‐Deficiency Anemia in Preadolescent Children and Adolescents , 1999, Helicobacter.

[307] R. Hunt,et al. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole , 1999, Alimentary pharmacology & therapeutics.

[308] R. Spiller,et al. The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer , 1999, Alimentary pharmacology & therapeutics.

[309] R. Holder,et al. Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. , 1999, European journal of gastroenterology & hepatology.

[310] Axon,et al. The optimal antibiotic combination in a 5‐day Helicobacter pylori eradication regimen , 1999, Alimentary pharmacology & therapeutics.

[311] A. Sonnenberg,et al. The effect of antibiotic therapy on bleeding from duodenal ulcer , 1999, American Journal of Gastroenterology.

[312] A. Blum,et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. , 1999, Gastroenterology.

[313] D. Graham,et al. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? , 1999, American Journal of Gastroenterology.

[314] G. Porro,et al. Is routine histological evaluation an accurate test for Helicobacter pylori infection? , 1999, Alimentary pharmacology & therapeutics.

[315] J. de Korwin,et al. Evaluation of a New Serologic Test for Diagnosis of Helicobacter pylori Infection in Children , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[316] R. Spiller,et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. , 1999, Gastroenterology.

[317] R. Knill-Jones,et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. , 1998, The New England journal of medicine.

[318] A. Blum,et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. , 1998, The New England journal of medicine.

[319] Pohle,et al. Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole—an open pilot study , 1998, Alimentary pharmacology & therapeutics.

[320] L. Laine,et al. Effect of Proton-Pump Inhibitor Therapy on Diagnostic Testing for Helicobacter pylori , 1998, Annals of Internal Medicine.

[321] V. Diehl,et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. , 1998, Blood.

[322] L. Corvaglia,et al. Detection of Helicobacter pylori infection in children with a standardized and simplified 13C-urea breath test. , 1998, Journal of pediatric gastroenterology and nutrition.

[323] L. Laine,et al. Has the impact of helicobacter pylori therapy on ulcer recurrence in the united states been overstated? , 1998, American Journal of Gastroenterology.

[324] H. Nagai,et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.

[325] P. Malfertheiner,et al. Performance of a Rapid Whole Blood Test for Helicobacter pylori in Primary Care: A German Multicenter Study , 1998, Helicobacter.

[326] D. Graham,et al. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. , 1998, The Journal of infectious diseases.

[327] D. Palli,et al. Short stature and Helicobacter pylori infection in Italian children: prospective multicentre hospital based case-control study , 1998, BMJ.

[328] J. Lambert,et al. The impact of Helicobacter pylori eradication on peptic ulcer healing , 1998, American Journal of Gastroenterology.

[329] P. Malfertheiner,et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. , 1998, British Journal of Cancer.

[330] R. Hunt,et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. , 1998, Gastroenterology.

[331] J. Yahalom,et al. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[332] H. Brenner,et al. Helicobacter pylori and Abdominal Symptoms: A Population-based Study Among Preschool Children in Southern Germany , 1998, Pediatrics.

[333] J. Holton,et al. Helicobacter pylori and diminished growth in children: is it simply a marker of deprivation? , 1998, Italian journal of gastroenterology and hepatology.

[334] D. Rothenbacher,et al. Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. , 1998, International journal of epidemiology.

[335] R. Hopkins. Current FDA-approved treatments for Helicobacter pylori and the FDA approval process. , 1997, Gastroenterology.

[336] S. Mönig,et al. Treatment and prognosis of gastric lymphoma. , 1997, The European journal of surgery = Acta chirurgica.

[337] T. Greiner,et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[338] B. Braden,et al. Endoscopy is not a risk factor for Helicobacter pylori infection--but medical practice is. , 1997, Gastrointestinal endoscopy.

[339] M. Stolte,et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. , 1997, Gastroenterology.

[340] M. Fujishima,et al. Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. , 1997, The American journal of gastroenterology.

[341] M. Stolte,et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. , 1997, Journal of the National Cancer Institute.

[342] A. Rosenwald,et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. , 1997, Cancer research.

[343] E. Kuipers,et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. , 1997, The American journal of gastroenterology.

[344] Mark Borodovsky,et al. The complete genome sequence of the gastric pathogen Helicobacter pylori , 1997, Nature.

[345] A. Blum,et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. , 1997, Gastroenterology.

[346] W. Chey,et al. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. , 1997, The American journal of gastroenterology.

[347] T. Hori,et al. Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori , 1997, European Journal of Pediatrics.

[348] J. L. Taylor,et al. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. , 1997, Archives of internal medicine.

[349] D. Graham,et al. The Best Gastric Site for Obtaining a Positive Rapid Urease Test , 1996, Helicobacter.

[350] S. Shapiro,et al. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product , 1996, The Lancet.

[351] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[352] J. Hyams,et al. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. , 1996, The Journal of pediatrics.

[353] J. DeLany,et al. Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. , 1996, American journal of epidemiology.

[354] S. Hill,et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis , 1996, BMJ.

[355] L. Irwig,et al. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. , 1996, The American journal of gastroenterology.

[356] J. V. D. van der Meer,et al. Value of laboratory investigations in clinical suspicion of cytomegalovirus‐induced upper gastrointestinal tract ulcerations in HIV‐infected patients , 1996, Journal of medical virology.

[357] D. Graham,et al. Helicobacter pylori in the drinking water in Peru. , 1996, Gastroenterology.

[358] M. Guslandi,et al. Symptomatic response to omeprazole in inflammatory bowel disease. , 1996, Journal of clinical gastroenterology.

[359] G. Treiber. The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. , 1996, The American journal of gastroenterology.

[360] J. Hallas,et al. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. , 1996, Scandinavian journal of gastroenterology.

[361] G. Guyatt,et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. , 1996, JAMA.

[362] C. Macarthur,et al. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. , 1995, JAMA.

[363] M. Stolte,et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection , 1995, European journal of gastroenterology & hepatology.

[364] J. Slattery,et al. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial. , 1995, Gut.

[365] P. Gaulard,et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[366] D. Jong,et al. Role of Helicobacter pylori eradication in high-grade MALT lymphoma , 1995, The Lancet.

[367] M. Blaser,et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. , 1995, Gastroenterology.

[368] M. Stolte,et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection , 1995, The Lancet.

[369] J. Tjandra,et al. Helicobacter pylori in peptic ulcer disease. , 1995, The Australian and New Zealand journal of surgery.

[370] F. Cavalli,et al. Eradication of Helicobacter pylori Infection in Primary Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue , 1995, Annals of Internal Medicine.

[371] M. Rawlins,et al. Prophylactic aspirin and risk of peptic ulcer bleeding , 1995, BMJ.

[372] M. Stolte,et al. Relationships between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. , 1995, Zeitschrift fur Gastroenterologie.

[373] A. Ferguson,et al. Successful Helicobacter pylori eradication incorporating a one‐week antibiotic regimen , 1995, Alimentary pharmacology & therapeutics.

[374] M. Schubert,et al. Helicobacter pylori and gastric lymphoma. , 1995, Gastroenterology.

[375] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[376] D. Graham,et al. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. , 1994, The American journal of gastroenterology.

[377] P. Chyou,et al. Helicobacter pylori Infection and the Risk for Duodenal and Gastric Ulceration , 1994, Annals of Internal Medicine.

[378] J. Dickinson,et al. Is omeprazole helpful in inflammatory bowel disease? , 1994, Journal of clinical gastroenterology.

[379] H. Goto,et al. A proposed staging system for primary gastric lymphoma , 1994, Cancer.

[380] F. Dewhirst,et al. Helicobacter pylori isolated from the domestic cat: public health implications , 1994, Infection and immunity.

[381] R. Warnke,et al. Helicobacter pylori infection and gastric lymphoma. , 1994, The New England journal of medicine.

[382] M. Stolte,et al. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease? , 1994, Gut.

[383] G. Guyatt,et al. Risk factors for gastrointestinal bleeding in critically ill patients , 1994 .

[384] I. Ng,et al. Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients. , 1993, The American journal of gastroenterology.

[385] P. Isaacson,et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori , 1993, The Lancet.

[386] F. Mégraud,et al. The cohort effect and Helicobacter pylori. , 1993, The Journal of infectious diseases.

[387] G. Bell,et al. Helicobacter pylori eradication. , 1993, The Practitioner.

[388] R. Hunt,et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. , 1992, The American journal of gastroenterology.

[389] D. Strachan,et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life , 1992, The Lancet.

[390] C. Doglioni,et al. High incidence of primary gastric lymphoma in northeastern Italy , 1992, The Lancet.

[391] D. Rattner,et al. Fulminant peptic ulcer disease in cardiac surgical patients: Pathogenesis, prevention, and management , 1992, Critical care medicine.

[392] P. Isaacson,et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma , 1991, The Lancet.

[393] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[394] D. Graham,et al. Water source as risk factor for Helicobacter pylori infection in Peruvian children , 1991, The Lancet.

[395] Alter Mj,et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.

[396] D. Forman,et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China , 1990, International journal of cancer.

[397] D. Graham,et al. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. , 1990, The American journal of gastroenterology.

[398] M. Stolte,et al. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? , 1989, Journal of clinical pathology.

[399] STRESS ULCER PROPHYLAXIS IN CRITICALLY ILL PATIENTS , 1989, The Lancet.

[400] M. Stolte,et al. Topographic association between active gastritis and Campylobacter pylori colonisation. , 1989, Journal of clinical pathology.

[401] D. Stringer,et al. Peptic ulcer disease in children: etiology, clinical findings, and clinical course. , 1988, Pediatrics.

[402] P. Isaacson,et al. Primary B‐cell gastric lymphoma—a reassessment of its histogenesis , 1987, The Journal of pathology.

[403] P. Isaacson,et al. Malignant lymphoma of mucosa‐associated lymphoid tissue , 1987, Histopathology.

[404] R. Summers,et al. National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.

[405] A. Schutt,et al. Primary gastric malignant lymphoma followed by gastric adenocarcinoma. Report of 4 cases and review of the literature , 1978, Cancer.

[406] D. Ettinger,et al. Gastric carcinoma 16 years after gastric lymphoma irradiation. , 1977, The American journal of gastroenterology.

[407] F. Foley,et al. Curling's Ulcer: A Clinical‐Pathology Study of 323 Cases , 1970, Annals of surgery.

[408] J APLEY,et al. Recurrent Abdominal Pains: A Field Survey of 1,000 School Children , 1958, Archives of disease in childhood.

[409] M. Ahmed,et al. Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication , 2007, Annals of Internal Medicine.

[410] L. Daly,et al. Age-specific incidence of Helicobacter pylori. , 2006, Gastroenterology.

[411] D. Forman,et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. , 2006, The Cochrane database of systematic reviews.

[412] D. Forman,et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. , 2006, The Cochrane database of systematic reviews.

[413] A. Bossuyt,et al. The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[414] T. Ishizaki,et al. Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. , 2005, Drug metabolism and pharmacokinetics.

[415] L. Torroba Álvarez,et al. [Helicobacter pylori infection in the child population in Spain: prevalence, related factors and influence on growth]. , 2005, Anales de pediatria.

[416] D. de Jong,et al. Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus. , 2005, Blood cells, molecules & diseases.

[417] F. Irani,et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. , 2007, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[418] J. Gisbert,et al. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. , 2004, Alimentary pharmacology & therapeutics.

[419] W. Fischbach,et al. [Helicobacter pylori infection in children and juveniles: an epidemiological study on prevalence, socio-economic factors and symptoms]. , 2003, Deutsche medizinische Wochenschrift.

[420] F. Mégraud,et al. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. , 2002, Microbial drug resistance.

[421] J. Y. Yáñez López,et al. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome. , 2002, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[422] M. Stolte,et al. Diagnostic accuracy of (13)C-urea breath test in the diagnosis of Helicobacter pylori infection in patients with partial gastric resection due to peptic ulcer disease: a prospective multicenter study. , 2001, Digestion.

[423] B. Koletzko,et al. Influence of age on 13C-urea breath test results in children. , 2000, Journal of pediatric gastroenterology and nutrition.

[424] M. Stolte,et al. Lack of effect of acid suppression therapy on gastric atrophy. , 2000, Gastroenterology.

[425] A. Scarpa,et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[426] J. Kleibeuker,et al. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis , 1999, American Journal of Gastroenterology.

[427] A. Barabino,et al. Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence. , 1999, Journal of pediatric gastroenterology and nutrition.

[428] T. Hirayama,et al. Divergence of virulence factors of Helicobacter pylori among clinical isolates does not correlate with disease specificity. , 1999, Journal of gastroenterology.

[429] C. Hawkey,et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. , 1998, Lancet.

[430] Y. Kodera,et al. The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. , 1998, Annals of surgery.

[431] R. Hunt,et al. Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. , 1997, Gut.

[432] G. Stevenson,et al. Infection with Helicobacter pylori. , 1996, AJR. American journal of roentgenology.

[433] M. Brennan,et al. Long-term follow-up after curative surgery for early gastric lymphoma. , 1996, Annals of surgery.

[434] W. Opferkuch,et al. Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin. , 1996, The American journal of gastroenterology.

[435] J. Parsonnet. The incidence of Helicobacter pylori infection. , 1995, Alimentary pharmacology & therapeutics.

[436] J. Deeks,et al. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. , 1995, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[437] M. Stolte,et al. Helicobacter heilmannii (formerly Gastrospirillum hominis) gastritis: an infection transmitted by animals? , 1994, Scandinavian journal of gastroenterology.

[438] K. Ewe,et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. , 1984, Gastroenterology.

[439] T. Wasserman,et al. Non-Hodgkin's lymphoma of the stomach. , 1983, The American journal of gastroenterology.

[440] K. Musshoff. Klinische Stadieneinteilung der Nicht-Hodgkin lymphome , 1977 .

[441] M. Staneva,et al. [Ménétrier's disease]. , 1975, Khirurgiia.